搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
New Atlas
1 小时
Cancer protein discovery reveals new treatment target
Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...
MedPage Today
18 小时
Practice-Changing Win for Aspirin in Colorectal Cancer
SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on ...
Cure Today
1 天
Aspirin May Reduce Recurrence in PI3K-mutated Colorectal Cancer
Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...
The American Journal of Managed Care
13 天
Ethnic Disparities Identified in Colorectal Cancer Diagnoses, Study Finds
New research examines how ethnicity impacts colorectal cancer diagnosis, early-onset colorectal cancer (CRC) prevalence, and ...
News Medical on MSN
11 天
New target identified for potential colorectal cancer treatment
Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the digestive system.
11 天
on MSN
Colorectal cancer treatment: New therapy could be achieved by blocking DUSP6 protein
Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the ...
EurekAlert!
13 天
NUS Medicine study discovers potential for new colorectal cancer treatment
The possibility of a new therapy for colorectal cancer could be achieved by blocking DUSP6, a protein that is important for ...
healthandpharma
10 天
FDA Approves Sotorasib and Panitumumab Combination: Doubling Survival for KRAS G12C-Mutated ...
The FDA has approved a novel combination therapy using Lumakras® (sotorasib) and Vectibix® (panitumumab) for adults with KRAS ...
The Independent Singapore
5 天
New discovery by NUS researchers could lead to breakthrough in colorectal cancer treatment
The study’s lead researcher, Associate Professor Zhang Yongliang from the Department of Microbiology & Immunology at NUS ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈